Bristol-Myers Squibb Co. (BMY)
The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.
Recs
SammyJ826
(94.47)
Submitted: 11/3/2009 4:22:44 PM :
Start Price:
$21.99
BMY Score:
+1.42
Strong dividend, strong earnings. This one adds some safety to my real life aggressive portfolio
Recs
jdcarcollector
(20.74)
Submitted: 11/3/2009 10:59:12 AM :
Start Price:
$21.82
BMY Score:
+1.00
Fat yield.
Recs
Wendykitty
(34.25)
Submitted: 10/26/2009 9:35:17 PM :
Start Price:
$21.97
BMY Score:
+2.96
BMY is a solid company with a great dividend. People will be looking for such a stable company to balance their portfolios. I don't think Obama's health care plan will hurt it either.
Recs
WiZlonex
(< 20)
Submitted: 10/25/2009 9:52:55 PM :
Start Price:
$22.22
BMY Score:
+3.06
Lilly is about to lose its protection (patents expiring). There will be rationalization in the industry as players take advantage of new generic-drug alternatives. BMY has saved the cash needed to make some good acquisitions, which will accelerate its performance.
Recs
bigmike7
(52.33)
Submitted: 10/23/2009 8:39:52 PM :
Start Price:
$22.26
BMY Score:
+2.70
good time to buy - good dividend @ 5.5% - real potential for takeover in near furure-eh
Recs
rexlove
(97.08)
Submitted: 10/22/2009 7:37:44 PM :
Start Price:
$22.58
BMY Score:
+2.60
safe high yield
Recs
acts412
(72.52)
Submitted: 10/10/2009 11:21:41 PM :
Start Price:
$22.59
BMY Score:
+0.12
positive independent ratings. best drug manufacturer. S&P 5 stars. 5.5% div. historically low PE of 13 x's trailing EPS.
Recs
rudcpr
(52.76)
Submitted: 10/10/2009 1:44:30 PM :
Start Price:
$22.85
BMY Score:
-0.33
Abilify for adjunctive treatment of depression has been a huge success and patients are reporting results within 1-2 weeks which is unprecedented for an antidepressant (unless it's placebo effect). Analysts are aware of the potential here, but I think the next set of earnings will beat.
Recs
richardrogers4
(65.06)
Submitted: 9/30/2009 3:19:33 AM :
Start Price:
$22.74
BMY Score:
-1.16
Momentum / defensive pick
Recs
30andholding
(92.75)
Submitted: 9/16/2009 2:27:46 PM :
Start Price:
$22.29
BMY Score:
+1.08
P/E is not overly high. There's a good dividend and they have enough cash on hand to completely cover their LT debt.
Recs
liketechxyz
(51.08)
Submitted: 9/15/2009 10:22:33 AM :
Start Price:
$21.89
BMY Score:
+1.11
Leading Pharma
Recs
Mliaom
(22.97)
Submitted: 9/13/2009 5:09:21 PM :
Start Price:
$22.01
BMY Score:
-0.76
Quality Med Related company, Bargain price, Great Dividend history. I like my chances.
Recs
DuffyRomerica
(75.52)
Submitted: 9/6/2009 1:55:24 PM :
Start Price:
$21.73
BMY Score:
-0.33
Passws the Geraldine Weiss criteria as of Sep 6, 2009
Recs
RINDER
(42.43)
Submitted: 9/4/2009 1:58:58 PM :
Start Price:
$21.69
BMY Score:
-1.37
High dividend yield, Underpriced. Low risk and steady growth
Recs
KhelSkie
(77.94)
Submitted: 8/31/2009 2:57:08 PM :
Start Price:
$21.74
BMY Score:
-1.25
Drug company that produces everyday items. Enough said.
Recs
frtedcrilly
(40.39)
Submitted: 8/26/2009 11:48:52 AM :
Start Price:
$21.71
BMY Score:
-3.35
well below average price, this company has at least 2 years to go on its shining light, Plavix, though this drug has seen some headwind recently, not enough to affect sales.Pipeline good, sales excellent.keeping it simple too, by not over-subscribing to takeover temptations
Recs
Momentum21
(66.44)
Submitted: 8/24/2009 11:29:01 PM :
Start Price:
$22.20
BMY Score:
-2.17
Another addition to my pharma collection
Recs
PuroDog
(82.89)
Submitted: 8/22/2009 5:42:04 AM :
Start Price:
$22.38
BMY Score:
-2.97
Best drugs I ever had
Recs
nosplits
(< 20)
Submitted: 8/12/2009 10:24:41 PM :
Start Price:
$21.49
BMY Score:
+1.02
Bristol Myers has just purchased a company, one that is costly not creating cash flow yet. Set back = Time Medex does have diamonds awaiting them with BMY's good management.
Recs
JDKeene
(93.22)
Submitted: 8/12/2009 1:01:31 PM :
Start Price:
$21.65
BMY Score:
-1.83
Ford Strong Buy, S&P (4 or 3 stars), Member of S&P 500
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 218 1 2 3 4 5 6 7 8 9 10 Next »